Effects of magnesium sulphate following spinal cord injury in rats

Beril Gok1, Ozerk Okutan, Etem Beskonakli

  • 1Department of Neurological Surgery, Ankara Ataturk Research and Education Hospital, Ankara, Turkey. berylgok@gmail.com

Insights

Magnesium sulphate treatment improved functional outcomes and reduced neutrophil infiltration after spinal cord injury in rats. This neuroprotective effect was observed in early clinical results and myeloperoxidase activity.

Area of Science:

  • Neuroscience
  • Traumatology
  • Pharmacology

Background:

  • Neutrophil infiltration contributes to secondary damage following spinal cord injury.
  • Myeloperoxidase (MPO) activity serves as a key indicator of neutrophil infiltration post-trauma.

Purpose of the Study:

  • To investigate the neuroprotective effects of magnesium sulphate on spinal cord injury in a rat model.
  • To assess the impact of magnesium sulphate on neutrophil infiltration by measuring MPO activity.

Main Methods:

  • Rats with induced spinal cord contusion injury were divided into five groups: control, injury only, vehicle, methylprednisolone sodium succinate (MPSS), and magnesium sulphate.
  • Functional recovery was evaluated using the inclined plane technique 24 hours post-injury.
  • Spinal cord tissue was analyzed for myeloperoxidase (MPO) activity to quantify neutrophil infiltration.

Main Results:

  • Magnesium sulphate treatment significantly improved early functional scores in rats with spinal cord injury.
  • Treatment with magnesium sulphate led to a notable decrease in MPO activity, indicating reduced neutrophil infiltration.
  • Methylprednisolone sodium succinate (MPSS) also demonstrated positive effects, though magnesium sulphate showed significant neuroprotection.

Conclusions:

  • Magnesium sulphate exhibits neuroprotective properties in the acute phase of spinal cord injury.
  • The treatment effectively mitigates secondary damage by reducing neutrophil infiltration.
  • Magnesium sulphate represents a potential therapeutic agent for managing acute spinal cord injury.